The resolution designates September of each year as "Duchenne Muscular Dystrophy Awareness Month" in New Jersey to raise awareness about Duchenne muscular dystrophy (DMD), a severe genetic disorder affecting approximately 1 in 3,500 male infants. DMD leads to progressive muscle degeneration and loss of function, often resulting in paralysis and serious cardiopulmonary complications. The average life expectancy for individuals with DMD is around 25 years, and while there is currently no cure, advancements in medical research have identified potential treatments that could improve patient outcomes.

The resolution emphasizes the importance of awareness and advocacy efforts in supporting individuals and families affected by DMD. It calls for the Governor to issue an annual proclamation recognizing September as DMD Awareness Month and encourages state agencies, organizations, and citizens to participate in awareness activities and programs. By designating this month, New Jersey aims to foster empathy, understanding, and community support while promoting access to treatment and research for this debilitating disease.